Tuesday, March 11, 2008

Bill Freytag, Ph.D. Appointed AlphaSniffer Board Chair

What do you get when combing Colorado-based Nobel Laureate technology (Dr. John Hall, 2005-Physics) with Colorado-based All-Star management (Dr. Bill Freytag, Chair & CEO Aspreva Pharma, Chair & CEO Myogen)? Answer…alphsniffer…who announced the appointment of Dr. J. William Freytag as the new Chairman of the Board of Directors. Congratulations to Founder and CEO Misha Plam, Ph.D. for assembling such an outstanding team around an outstanding platform technology.

To say Dr. Freytag has been busy these last few years would be an understatement. Read more about his value creating ways (here). In addition to his current work with AlphaSniffer Dr. Freytag is also serving on the Board of Directors for Sierra Neuropharmaceuticals, ARCA Discovery and Immunicon (NASDAQ: IMMC), and brings particular expertise in the filed of diagnostics having formerly served as President of Molecular Diagnostics at Boehringer Mannheim (acquired by Roche).

AlphaSniffer continues to make incredible progress having already established proof-of-concept with their proprietary technology for real-time, sensitive, label-free detection of medically and commercially important molecules such as DNA, proteins, toxins, contaminants and other molecules. There are numerous potential applications of this real-time detection platform including:

  • Medical research
  • Personalized medicine and diagnostics
  • Pharmaceutical process control
  • Defense and homeland security
  • And, a host of industrial applications
It will certainly be interesting to observe the developing commercialization trajectory. Learn more about the technology and applications at the new alphasniffer website (here) or http://alphasniffer.com

***NOTE*** Take a look at the new Boulder Biotech Company Tree (HERE)!
***NOTE*** Read the new eBook CLSDF 2007 - What's In A Year? (HERE)!

If you enjoyed this post get free email or RSS updates (here).

No comments: